EP3247707
4-Metýlsúlfónýl-setin píperidín-úrea-efnasambönd sem eru nytsamleg til meðhöndlunar á hjartaröskunum eins og hjartavöðvakvilla með ofþenslu (DCM)
:
EP einkaleyfi í gildi á Íslandi:
21.1.2016:
31.5.2023:
16702652.5
:
14.8.2023:
15.9.2023
:
20.1.2036:
20.1.2026:
31.1.2026
:
4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS USEFUL FOR THE TREATMENT OF CARDIAC DISORDERS SUCH AS DILATED CARDIOMYOPATHY (DCM)
21.1.2016
31.5.2023
14.8.2023
15.9.2023
20.1.2026
:
MyoKardia, Inc.:
1000 Sierra Point Parkway, Brisbane, CA 94005, US
:
OSLOB, Johan:
California 94005, US
:
AUBELE, Danielle:
California 94005, US
:
KIM, Jae:
California 94005, US
:
MCDOWELL, Robert:
California 94005, US
:
SONG, Yonghong:
California 94005, US
:
SRAN, Arvinder:
California 94005, US
:
ZHONG, Min:
California 94005, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201562106571 P:
22.1.2015:
US
:
US2016014365:
21.1.2016
:
C07D 401/14, C07D 401/02, C07D 407/02, C07D 407/14, C07D 409/02, C07D 411/14, C07D 471/04, A61K 31/435, A61P 9/04
: 9
: 18.12.2023
: 20.1.2025
: Árnason Faktor ehf.
: 10
: 10.12.2024
: 20.1.2026
: Árnason Faktor ehf.